The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. This evidence concerns the gene SLC22A4 and chronic myelogenous leukemia, BCR-ABL1 positive.